Pfizer building’s column scare tests Midtown East’s biggest conversion bet
All eyes were on Midtown East last week after steel columns buckled inside the Pfizer building conversion project, forcing evacuations at the site and nearby buildings on Tuesday. The structural failures at 235 East 42nd Street — where Nathan Berman’s MetroLoft Management and investor David Werner are converting the pharmaceutical firm’s former headquarters into 1,600 apartments — captured national headlines and sparked surprise among industry players, as well as a probe by the city’s Department of Investigation into their cause. Though the building has since been stabilized, its near-collapse — and the spotlight it attracted — also raises questions about […]
This article originally appeared on The Real Deal. Click here to read the full story.
Categories
Recent Posts

Malaysian Tycoon Lee Yeow Seng-Led IOI Properties To Raise $490 Million From REIT’s IPO

Choose Your Florida Fantasy: Life At The Water’s Edge

Load-Bearing Wall: Why Can’t You Knock Down Any Wall in Your House?

Former Compass Development Marketing employee alleges sex, age discrimination

7 Home Repairs You Should Never DIY (and the Projects Worth Tackling Yourself)

Ben Beitel sells luxury Brooklyn building for $52M

Gary Barnett buys air rights for Midtown supertall

New brand, same problems: Late commissions plaguing The Agency One Rock

Multifamily vet launches AI platform for NYC rentals

How Accurate Is the Zillow Zestimate in Seattle?


